Cloning and expression of 51-kDa antigenic protein of Neorickettsia risticii NR-JA1.

The research article is about a study conducted to clone and express the 51-kDa antigenic protein of Neorickettsia risticii NR-JA1, which is a bacteria causing acute diarrheal syndrome in horses. The main objective of the study was to explore the possible development of a more effective diagnostic test and potential DNA-based vaccine for Potomac horse fever.

Research Methodology

• The study involved the cultivation of the Korean isolate of N. risticii NR-JA1 in the mouse macrophage cell line P388D1.
• The researchers successfully cloned and amplified the complete ORF of p51 antigenic protein gene and incorporated it into pQE32 and pcDNA3.1 vectors, resulting in the clones named pQE32/Nr-51 and pcDNA3.1/Nr-51.
• The recombinant p51 (rp51) protein antigen was then expressed in E. coli (pQE32/Nr-51) and the COS-7 cell line (pcDNA3.1/Nr-51).

Results and Findings

• They found that the rp51 protein antigen exhibited immunoreactivity with anti-mouse p51 antibodies. This finding suggests a potential ability of the p51 antigen to stimulate an immune response.
• BALB/c mice were inoculated with the recombinant plasmid DNA (pcDNA3.1/Nr-51). The collected serum samples from these mice showed IgG ELISA titers of 1:128, indicating a strong immune response against the antigen.
• A noteworthy reaction was observed in a Western immunoblot assay as the serum samples demonstrated robust reactivity to rp51 articulated in the COS-7 cell line transfected with pcDNA3.1/Nr-51.

Implications of the Study

• The key conclusion drawn from this research is that N. risticii p51 protein could be a dominant antigen and may play an essential role in the development of serological or molecular diagnostic tests.
• It also indicates potential for the creation of an enhanced recombinant DNA-based vaccine against Potomac horse fever, which could significantly improve treatment measures for the disease in the horse population.

The findings of this study contribute meaningful knowledge to the field and highlight that further exploration and confirmation of p51 protein’s function and effectiveness in vaccine development are necessary.